• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pandemic influenza (H1N1): Impact on lung transplant recipients and candidates

tetano

Editor, Senior Moderator
J Heart Lung Transplant. 2010 Jun 15. [Epub ahead of print]
Pandemic influenza (H1N1): Impact on lung transplant recipients and candidates.

Fox BD, Raviv Y, Rozengarten D, Rusanov V, Bakal I, Kramer MR.

Pulmonary Institute, Rabin Medical Center, Beilinson Campus, Petach Tiqwa, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Abstract

BACKGROUND: The year 2009 was notable for the outbreak of a novel strain of influenza A (H1N1). We report the outcomes of H1N1 infection in a large cohort of lung transplant (LTx) recipients and candidates. METHODS: This was a retrospective review of 22 suspected cases of H1N1 influenza screened using real-time polymerase chain reaction from nasal secretions. There were 15 confirmed cases (10 LTx recipients, 5 LTx candidates). RESULTS: All patients were treated with oseltamivir at the time of the first clinical assessment. In the LTx recipients group, 7 of the 10 confirmed cases were treated at home with oseltamivir alone. Three patients were admitted with complications (2 pneumonia, 1 acute rejection). Two patients required mechanical ventilation. Two patients had prolonged viral shedding. No deaths occurred among the LTx recipients. In the 5 LTx candidates with confirmed H1N1, 2 deaths occurred from pneumonia and acute respiratory distress syndrome. CONCLUSIONS: Influenza H1N1 had a significant complication rate amongst LTx recipients and a high mortality rate amongst LTx candidates. Copyright ? 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

PMID: 20558087 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/20558087
 
Back
Top Bottom